India's Cadila/Zydus Acquire Eight AZ Brands

Jan 24, 2017

The Economic Times

AstraZeneca has divested its brands in anti-infective and women’s health portfolio to Zydus Healthcare, a subsidiary of Cadila Healthcare, according to an article in The Economic Times.

As part of the agreement, AZ will sell the following brands of Bricarex, Bricarex-A, Bricanyl, Xylocard, Ceriviprime, Prostodin, Partocin and Primiprost in India to Zydus Healthcare; these brands were discontinued by the company in the Indian market, the story said.

Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments